THE IMPORTANCE OF BODY COMPOSITION MEASUREMENTS DURING LENVATINIB TREATMENT IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA

被引:0
作者
Yamaoka, Kenji [1 ]
Kawaoka, Tomokazu [1 ]
Kosaka, Masanari [1 ]
Johira, Yusuke [1 ]
Shirane, Yuki [1 ]
Miura, Ryoichi [1 ]
Yano, Shigeki [1 ]
Murakami, Serami [1 ]
Amioka, Kei [1 ]
Naruto, Kensuke [1 ]
Ando, Yuwa [1 ]
Kosaka, Yumi [1 ]
Uchikawa, Shinsuke [1 ]
Kodama, Kenichiro [1 ]
Uchida, Takuro [1 ]
Fujino, Hatsue [1 ]
Ono, Atsushi [1 ]
Nakahara, Takashi [1 ]
Murakami, Eisuke [1 ]
Okamoto, Wataru [2 ]
Yamauchi, Masami [1 ]
Miki, Daiki [1 ]
Imamura, Michio [1 ]
Chayama, Kazuaki [3 ]
Aikata, Hiroshi [1 ]
机构
[1] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Gastroenterol & Metab, Hiroshima, Japan
[2] Hiroshima Univ, Canc Treatment Ctr, Hiroshima, Japan
[3] Hiroshima Univ, Dept Collaborat Res Lab Med Innovat, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
4508
引用
收藏
页码:S1386 / S1387
页数:2
相关论文
共 50 条
[41]   Colitis induced by Lenvatinib in a patient with advanced hepatocellular carcinoma [J].
Miyajima, Saori ;
Tsuji, Kunihiro ;
Kito, Yosuke ;
Yoshida, Naohiro ;
Matsunaga, Kazuhiro ;
Tsuji, Shigetsugu ;
Katayanagi, Kazuyoshi ;
Yonezawa, Miwa ;
Kubo, Anna ;
Ushijima, Kahori ;
Minato, Hiroshi ;
Doyama, Hisashi .
CLINICAL JOURNAL OF GASTROENTEROLOGY, 2021, 14 (01) :187-192
[42]   Controlling Major Portal Vein Invasion Progression during Lenvatinib Treatment by Carbon-Ion Radiotherapy in Patients with Advanced Hepatocellular Carcinoma [J].
Yoshida, Ryoi ;
Koroki, Keisuke ;
Makishima, Hirokazu ;
Ogasawara, Sadahisa ;
Ishino, Takamasa ;
Ogawa, Keita ;
Nakagawa, Miyuki ;
Fujiwara, Kisako ;
Unozawa, Hidemi ;
Iwanaga, Terunao ;
Fujita, Naoto ;
Sakuma, Takafumi ;
Kanzaki, Hiroaki ;
Kobayashi, Kazufumi ;
Kanogawa, Naoya ;
Kiyono, Soichiro ;
Nakamura, Masato ;
Kondo, Takayuki ;
Saito, Tomoko ;
Nakagawa, Ryo ;
Suzuki, Eiichiro ;
Ooka, Yoshihiko ;
Nakamoto, Shingo ;
Tawada, Akinobu ;
Chiba, Tetsuhiro ;
Arai, Makoto ;
Kaneko, Takashi ;
Wakatsuki, Masaru ;
Kato, Jun ;
Tsuji, Hiroshi ;
Kato, Naoya .
CASE REPORTS IN ONCOLOGY, 2021, 14 (02) :1103-1110
[43]   Lenvatinib acts as the salvage therapy for advanced hepatocellular carcinoma [J].
Hsieh, M-C. ;
Su, Y-L. ;
Chen, Y-Y. ;
Liu, C-T. ;
Chen, Y-H. ;
Chiu, T-J. ;
Pei, S-N. ;
Wu, C-C. ;
Rau, K-M. .
ANNALS OF ONCOLOGY, 2018, 29 :57-57
[44]   Colitis induced by Lenvatinib in a patient with advanced hepatocellular carcinoma [J].
Saori Miyajima ;
Kunihiro Tsuji ;
Yosuke Kito ;
Naohiro Yoshida ;
Kazuhiro Matsunaga ;
Shigetsugu Tsuji ;
Kazuyoshi Katayanagi ;
Miwa Yonezawa ;
Anna Kubo ;
Kahori Ushijima ;
Hiroshi Minato ;
Hisashi Doyama .
Clinical Journal of Gastroenterology, 2021, 14 :187-192
[45]   Comparison of stereotactic body radiotherapy with and without lenvatinib for advanced hepatocellular carcinoma: a propensity score analysis [J].
Quan Wang ;
Xiaoquan Ji ;
Jing Sun ;
Wengang Li ;
Xuezhang Duan ;
Aimin Zhang .
Journal of Cancer Research and Clinical Oncology, 2023, 149 :7441-7452
[46]   Comparison of stereotactic body radiotherapy with and without lenvatinib for advanced hepatocellular carcinoma: a propensity score analysis [J].
Wang, Quan ;
Ji, Xiaoquan ;
Sun, Jing ;
Li, Wengang ;
Duan, Xuezhang ;
Zhang, Aimin .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (10) :7441-7452
[47]   Comprehensive Treatment of Trans-Arterial Chemoembolization Plus Lenvatinib Followed by Camrelizumab for Advanced Hepatocellular Carcinoma Patients [J].
Liu, Juanfang ;
Li, Zhen ;
Zhang, Wenguang ;
Lu, Huibin ;
Sun, Zhanguo ;
Wang, Guozheng ;
Han, Xinwei .
FRONTIERS IN PHARMACOLOGY, 2021, 12
[48]   Significance of Physical Status and Liver Function Reserve for Outcome of Patients with Advanced Hepatocellular Carcinoma Receiving Lenvatinib Treatment [J].
Chan, Kun-Ming ;
Lai, Yin ;
Hung, Hao-Chien ;
Lee, Jin-Chiao ;
Cheng, Chih-Hsien ;
Wang, Yu-Chao ;
Wu, Tsung-Han ;
Lee, Chen-Fang ;
Wu, Ting-Jung ;
Chou, Hong-Shiue ;
Wang, Ching-Ting ;
Chai, Pei-Mei ;
Lien, Hsin-Yi ;
Lee, Wei-Chen .
JOURNAL OF HEPATOCELLULAR CARCINOMA, 2023, 10 :281-290
[49]   Comparative analysis of liver functional reserve during lenvatinib and sorafenib for advanced hepatocellular carcinoma [J].
Terashima, Takeshi ;
Yamashita, Tatsuya ;
Takata, Noboru ;
Toyama, Tadashi ;
Shimakami, Tetsuro ;
Takatori, Hajime ;
Arai, Kuniaki ;
Kawaguchi, Kazunori ;
Kitamura, Kazuya ;
Yamashita, Taro ;
Sakai, Yoshio ;
Mizukoshi, Eishiro ;
Honda, Masao ;
Kaneko, Shuichi .
HEPATOLOGY RESEARCH, 2020, 50 (07) :871-884
[50]   Efficacy of rechallenge transcatheter arterial chemoembolization after lenvatinib treatment for advanced hepatocellular carcinoma [J].
Uchida-Kobayashi, Sawako ;
Kageyama, Ken ;
Takemura, Shigekazu ;
Matsumoto, Kazuhiro ;
Odagiri, Naoshi ;
Jogo, Atsushi ;
Kotani, Kohei ;
Kozuka, Ritsuzo ;
Motoyama, Hiroyuki ;
Kawamura, Etsushi ;
Hagihara, Atsushi ;
Yamamoto, Akira ;
Fujii, Hideki ;
Tanaka, Shogo ;
Enomoto, Masaru ;
Tamori, Akihiro ;
Miki, Yukio ;
Kubo, Shoji ;
Kawada, Norifumi .
JGH OPEN, 2022, 6 (11) :754-762